Reduced binding of apoE4 to complement factor H promotes amyloid‐β oligomerization and neuroinflammation

L Chernyaeva, G Ratti, L Teirilä, S Fudo, U Rankka… - EMBO …, 2023 - embopress.org
The APOE4 variant of apolipoprotein E (apoE) is the most prevalent genetic risk allele
associated with late‐onset Alzheimer's disease (AD). ApoE interacts with complement …

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

LM Tai, S Mehra, V Shete, S Estus, GW Rebeck… - Molecular …, 2014 - Springer
The APOE4 allele of apolipoprotein E (apoE) is the greatest genetic risk factor for
Alzheimer's disease (AD) compared to APOE2 and APOE3. Amyloid-β (Aβ), particularly in a …

[PDF][PDF] ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

T Kanekiyo, H Xu, G Bu - Neuron, 2014 - cell.com
Among the three human apolipoprotein E (apoE) isoforms, apoE4 increases the risk of
Alzheimer's disease (AD). While transporting cholesterol is a primary function, apoE also …

[HTML][HTML] The important interface between apolipoprotein E and neuroinflammation in Alzheimer's disease

CM Kloske, DM Wilcock - Frontiers in immunology, 2020 - frontiersin.org
Alzheimer's disease (AD) is the most prevalent form of neurodegenerative disease, currently
affecting over 5 million Americans with projections expected to rise as the population ages …

Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro

PL McGeer, DG Walker, RE Pitas, RW Mahley… - Brain research, 1997 - Elsevier
Apolipoprotein E4 (ApoE4) increases the risk of late-onset Alzheimer's disease (AD). It binds
tightly to β-amyloid protein (A β), which is known to activate the classical complement …

[HTML][HTML] Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-Aβ interaction and Aβ fibrillation

HJ Moon, V Haroutunian, L Zhao - Neurobiology of disease, 2022 - Elsevier
The APOE genotype is the most prominent genetic risk factor for the development of late-
onset Alzheimer''s disease (LOAD); however, the underlying mechanisms remain unclear. In …

A flow cytometry–based in vitro assay reveals that formation of apolipoprotein E (ApoE)–amyloid beta complexes depends on ApoE isoform and cell type

E Kara, JD Marks, AD Roe, C Commins, Z Fan… - Journal of Biological …, 2018 - ASBMB
Apolipoprotein E (ApoE) is a secreted apolipoprotein with three isoforms, E2, E3, and E4,
that binds to lipids and facilitates their transport in the extracellular environment of the brain …

Understanding the basis for the association of apoE4 with Alzheimer's disease: opening the door for therapeutic approaches

N Zhong, KH Weisgraber - Current Alzheimer Research, 2009 - ingentaconnect.com
Apolipoprotein E4 (apoE4) is the major genetic risk factor for Alzheimer's disease (AD) by an
as yet to be defined mechanism. Since the structure or biophysical properties of a protein …

Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition

GA Rodriguez, LM Tai, MJ LaDu… - Journal of …, 2014 - Springer
Background Having the apolipoprotein E4 (APOE-ϵ4) allele is the strongest genetic risk
factor for the development of Alzheimer's disease (AD). Accumulation of amyloid beta (Aβ) in …

Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes

WS Chung, PB Verghese… - Proceedings of the …, 2016 - National Acad Sciences
The strongest genetic risk factor influencing susceptibility to late-onset Alzheimer's disease
(AD) is apolipoprotein E (APOE) genotype. APOE has three common isoforms in humans …